福安药业(300194.SZ)：头孢托仑匹酯颗粒收到药品注册证书

Core Viewpoint - Fuan Pharmaceutical (300194.SZ) has received a drug registration certificate from the National Medical Products Administration for its product, Cefotolan Pivoxil Granules, which is indicated for various infections caused by sensitive bacteria [1] Group 1: Company Developments - Fuan Pharmaceutical's wholly-owned subsidiary, Qingyutang Pharmaceutical Co., Ltd., has been granted a registration certificate for Cefotolan Pivoxil Granules [1] - The drug is suitable for treating superficial and deep skin infections, lymphangitis, chronic pyoderma, and other secondary infections [1] Group 2: Product Indications - Cefotolan Pivoxil Granules are indicated for a wide range of conditions including abscesses, pharyngitis, laryngitis, tonsillitis, acute bronchitis, pneumonia, and chronic respiratory diseases [1] - The product also addresses infections related to otitis media, sinusitis, periodontitis, jaw inflammation, cystitis, pyelonephritis, scarlet fever, and whooping cough [1]